St. Paul's Hospital · IT
Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Lung Cancer Treatments and Mutations.
AI performance for nodule volume doubling time in the follow-up of the UKLS lung cancer screening study compared to expert consensus and histological validation.
Incidence and lung cancer probability of new nodules in the UK lung screening trial
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening.
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data
Histological proven AI performance in the UKLS CT lung cancer screening study: Potential for workload reduction.
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data.
Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer.
Current evidence of low-dose CT screening benefit.
The lung cancer screening marathon after baseline: evidence from incidence nodules.
Supplementary Figure S3 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Materials S1 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S5 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S7 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Data from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S1 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Table S4 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Supplementary Table S1 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S6 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Table S2 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Table S5 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S2 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Table S3 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
Supplementary Figure S4 from Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study.
Study rationale and design of the PEOPLHE trial.
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study